Tag: William Blair
May 8, 2018
AxoGen Announces Proposed Public Offering of Common Stock
AxoGen (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced today that it has... April 9, 2018
Carbon Black Files Registration Statement for Proposed Initial Public Offering
Carbon Black, a cybersecurity innovator and a leading provider of next-generation endpoint security announced it has publicly filed a registration... January 25, 2018
Albireo Prices $65.0 Million Public Offering of Common Stock
Albireo Pharma (Nasdaq:ALBO) a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the pricing of... January 22, 2018
BeiGene Announces Closing of $800 Million Public Offering
BeiGene (NASDAQ:BGNE) a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment... January 19, 2018
BeiGene Announces Pricing of $750 Million Public Offering
BeiGene (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment...
August 1, 2017
FDA Advisory Committee Sends Dynavax Stock Soaring
Dynavax Technologies saw its stock jump over 70 percent on Monday thanks to a favorable review from the US Food... June 2, 2017